An Introduction to High Content Screening: Imaging Technology, Assay Development, and Data Analysis in Biology and Drug Discovery by Haney, Steven A.

An Introduction to High Content Screening: Imaging Technology, Assay Development, and Data Analysis in Biology and Drug Discovery (Hardcover) (ISBN-13: 9780470624562)

Vendor: Steven A. Haney
Product type: Books
Format: Hardcover
$144.95
$144.95
$144.95
Subtotal: $144.95
An Introduction to High Content Screening: Imaging Technology, Assay Development, and Data Analysis in Biology and Drug Discovery by Haney, Steven A.

An Introduction to High Content Screening: Imaging Technology, Assay Development, and Data Analysis in Biology and Drug Discovery

$144.95
An Introduction to High Content Screening: Imaging Technology, Assay Development, and Data Analysis in Biology and Drug Discovery by Haney, Steven A.

An Introduction to High Content Screening: Imaging Technology, Assay Development, and Data Analysis in Biology and Drug Discovery

$144.95
Format: Hardcover
Description
Description
x


Using a collaborative and interdisciplinary author base with experience in the pharmaceutical industry and academia, this book is a practical resource for high content (HC) techniques.

- Instructs readers on the fundamentals of high content screening (HCS) techniques
- Focuses on practical and widely-used techniques like image processing and multiparametric assays
- Breaks down HCS into individual modules for training and connects them at the end
- Includes a tutorial chapter that works through sample HCS assays, glossary, and detailed appendices



Author: Steven A. Haney
ISBN-10: 0470624566
ISBN-13: 9780470624562
Publisher: Wiley
Language: English
Published: 01/07/2015
Pages: 352
Format: Hardcover
Weight: 1.30lbs
Size: 9.30h x 6.20w x 0.90d
By Steven A. Haney
By Steven A. Haney
x
Steven Haney is a Senior Research Advisor and Group Leader at Eli Lilly and Company. He edited the book High Content Screening: Science, Techniques, and Applications (Wiley, 2008).

Douglas Bowman is an Associate Scientific Fellow at Takeda Pharmaceuticals.

Arijit Chakravarty is the Director of Modeling and Simulation (DMPK) at Takeda Pharmaceuticals.

Anthony Davies is Center Director, Translational Cell Imaging, Queensland University Of Technology, Queensland, Australia.

Caroline Shamu is the Director of the ICCB-Longwood Screening Facility at Harvard Medical School.

Recently Viewed Products